Trending Now
Should Wall Street be worried about Monkeypox
The World Health Organization reported 92 cases in 12 countries as of Saturday, with another 28 suspected cases under investigation. Cases have...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Inovio Pharmaceuticals Inc. (NASDAQ:INO) Responds To FDA Questions On Halted Phase...
Inovio Pharmaceuticals Inc. (NASDAQ:INO) has responded to questions from the FDA regarding INO-4800 and the Cellectra vaccine delivery device. The FDA had imposed a...
MAKE IT MODERN
LATEST REVIEWS
iBio Inc. (NYSEAMERICAN:IBIO) To Announce Q1 FY2021 Results On November 16,...
iBio Inc. (NYSEAMERICAN:IBIO) has announced that it will report fiscal first-quarter 2021 financial results on November 16, 2020, after the market close.
The company management...
MAKE IT MODERN
PERFORMANCE TRAINING
2022 Could Be Another Gangbusters for Cybersecurity Stock (SFET, CRWD, ZS, OKTA, PANW, S)
There is no doubt that work from home has led to significant increase in security challenges as cloud computing and remote work...
Pot Stock Outperformance and How to Play It (GRWG, MEDH, TLRY)
The monster combination of Aphria and Tilray is a loadstone that has sparked a faith-based move by investors into the cannabis space...
Microsoft (MSFT) post disappointing revenue forecast for current quarter
Software giant Microsoft (MSFT), exceeded analysts' predictions for per-share earnings in the second quarter of its fiscal year. However, its revenue was...
Protalix BioTherapeutics Inc. (NYSEAMERICAN:PLX) And Cheisi Submit BLA for PRX-102 in Treatment of Fabry...
Protalix BioTherapeutics Inc. (NYSEAMERICAN:PLX) and Chiesi Global Rare Diseases have announced that they have submitted a Biologics License Application to the FDA for pegunigalsidase...
BridgeBio Pharma Inc. (NASDAQ:BBIO) Partners With Institutions On Development Of Genetically Driven Disease Therapies
BridgeBio Pharma Inc. (NASDAQ:BBIO) has announced the signing of collaboration agreements with John Hopkins University and the University of Florida to advance treatments for...
MAKE IT MODERN
